These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 27997054)

  • 1. Stereotactic body radiotherapy for recurrent head and neck cancer: A critical review.
    Baliga S; Kabarriti R; Ohri N; Haynes-Lewis H; Yaparpalvi R; Kalnicki S; Garg MK
    Head Neck; 2017 Mar; 39(3):595-601. PubMed ID: 27997054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant stereotactic body radiotherapy±cetuximab following salvage surgery in previously irradiated head and neck cancer.
    Vargo JA; Kubicek GJ; Ferris RL; Duvvuri U; Johnson JT; Ohr J; Clump DA; Burton S; Heron DE
    Laryngoscope; 2014 Jul; 124(7):1579-84. PubMed ID: 24123056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salvage stereotactic reirradiation with or without cetuximab for locally recurrent head-and-neck cancer: a feasibility study.
    Comet B; Kramar A; Faivre-Pierret M; Dewas S; Coche-Dequeant B; Degardin M; Lefebvre JL; Lacornerie T; Lartigau EF
    Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):203-9. PubMed ID: 22331006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of nomogram-based prediction of survival probability after salvage re-irradiation of head and neck cancer.
    Shikama N; Kumazaki Y; Tsukamoto N; Ebara T; Makino S; Abe T; Nakahira M; Sugasawa M; Kato S
    Jpn J Clin Oncol; 2013 Feb; 43(2):154-60. PubMed ID: 23242582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of hypofractionated stereotactic body reirradiation in head and neck cancer: Long-term follow-up of a large series.
    Kress MA; Sen N; Unger KR; Lominska CE; Deeken JF; Davidson BJ; Newkirk KA; Hwang J; Harter KW
    Head Neck; 2015 Oct; 37(10):1403-9. PubMed ID: 24824359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereotactic Body Radiation Therapy for Recurrent Head and Neck Cancer.
    Ling DC; Vargo JA; Heron DE
    Cancer J; 2016; 22(4):302-6. PubMed ID: 27441751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of tumor volume and radiotherapy dose on outcome in previously irradiated recurrent squamous cell carcinoma of the head and neck treated with stereotactic body radiation therapy.
    Rwigema JC; Heron DE; Ferris RL; Andrade RS; Gibson MK; Yang Y; Ozhasoglu C; Argiris AE; Grandis JR; Burton SA
    Am J Clin Oncol; 2011 Aug; 34(4):372-9. PubMed ID: 20859194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of stereotactic body radiotherapy in reirradiation of head and neck cancer recurrence.
    Román A A; Jodar C; Perez-Rozos A; Lupiañez-Perez Y; Medina JA; Gomez-Millan J
    Crit Rev Oncol Hematol; 2018 Feb; 122():194-201. PubMed ID: 29373181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carotid Dosimetry and the Risk of Carotid Blowout Syndrome After Reirradiation With Head and Neck Stereotactic Body Radiation Therapy.
    Gebhardt BJ; Vargo JA; Ling D; Jones B; Mohney M; Clump DA; Ohr JP; Ferris RL; Heron DE
    Int J Radiat Oncol Biol Phys; 2018 May; 101(1):195-200. PubMed ID: 29398127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multi institutional phase II study of concomitant stereotactic reirradiation and cetuximab for recurrent head and neck cancer.
    Lartigau EF; Tresch E; Thariat J; Graff P; Coche-Dequeant B; Benezery K; Schiappacasse L; Degardin M; Bondiau PY; Peiffert D; Lefebvre JL; Lacornerie T; Kramar A
    Radiother Oncol; 2013 Nov; 109(2):281-5. PubMed ID: 24262821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereotactic Body Radiotherapy for Recurrent Unresectable Head and Neck Cancers.
    Strom T; Wishka C; Caudell JJ
    Cancer Control; 2016 Jan; 23(1):6-11. PubMed ID: 27009451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of HPV status in the re-irradiation of recurrent and second primary cancers of the head and neck.
    Velez MA; Wang PC; Hsu S; Chin R; Beron P; Abemayor E; St John M; Chen AM
    Am J Otolaryngol; 2018; 39(3):257-260. PubMed ID: 29433815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Examining tumor control and toxicity after stereotactic body radiotherapy in locally recurrent previously irradiated head and neck cancers: implications of treatment duration and tumor volume.
    Vargo JA; Heron DE; Ferris RL; Rwigema JC; Kalash R; Wegner RE; Ohr J; Burton S
    Head Neck; 2014 Sep; 36(9):1349-55. PubMed ID: 24038398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Multi-institutional Comparison of SBRT and IMRT for Definitive Reirradiation of Recurrent or Second Primary Head and Neck Cancer.
    Vargo JA; Ward MC; Caudell JJ; Riaz N; Dunlap NE; Isrow D; Zakem SJ; Dault J; Awan MJ; Higgins KA; Hassanadeh C; Beitler JJ; Reddy CA; Marcrom S; Boggs DH; Bonner JA; Yao M; Machtay M; Siddiqui F; Trotti AM; Lee NY; Koyfman SA; Ferris RL; Heron DE
    Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):595-605. PubMed ID: 28899556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term follow-up of stereotactic radiosurgery for head and neck malignancies.
    Owen D; Iqbal F; Pollock BE; Link MJ; Stien K; Garces YI; Brown PD; Foote RL
    Head Neck; 2015 Nov; 37(11):1557-62. PubMed ID: 24912475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of Severe Toxicity According to Site of Recurrence in Patients Treated With Stereotactic Body Radiation Therapy for Recurrent Head and Neck Cancer.
    Ling DC; Vargo JA; Ferris RL; Ohr J; Clump DA; Yau WW; Duvvuri U; Kim S; Johnson JT; Bauman JE; Branstetter BF; Heron DE
    Int J Radiat Oncol Biol Phys; 2016 Jul; 95(3):973-980. PubMed ID: 27302512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salvage stereotactic re-irradiation with CyberKnife for locally recurrent head and neck cancer: a single center experience.
    Bonomo P; Cipressi S; Iermano C; Bonucci I; Masi L; Doro R; Favuzza V; Paiar F; Simontacchi G; Meattini I; Greto D; Agresti B; Livi L; Biti G
    Tumori; 2014; 100(3):278-83. PubMed ID: 25076238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereotactic Body Radiotherapy (SBRT) for primary and recurrent head and neck tumors.
    Lim CM; Clump DA; Heron DE; Ferris RL
    Oral Oncol; 2013 May; 49(5):401-6. PubMed ID: 23332685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stereotactic body radiation therapy for primary, recurrent, and metastatic tumors in the head-and-neck region.
    Siddiqui F; Patel M; Khan M; McLean S; Dragovic J; Jin JY; Movsas B; Ryu S
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1047-53. PubMed ID: 19327895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereotactic body radiotherapy for recurrent squamous cell carcinoma of the head and neck: results of a phase I dose-escalation trial.
    Heron DE; Ferris RL; Karamouzis M; Andrade RS; Deeb EL; Burton S; Gooding WE; Branstetter BF; Mountz JM; Johnson JT; Argiris A; Grandis JR; Lai SY
    Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1493-500. PubMed ID: 19464819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.